Brief: Pharming Group Says First Patient Enrolled in Phase III Clinical Trial Of Leniolisib For The Treatment Of APDS In Japan
09/08/2023 06:05
Aug 9 (Reuters) - Pharming Group NV PHAR.AS :
* PHARMING ANNOUNCES FIRST PATIENT ENROLLED IN PHASE III
CLINICAL
TRIAL OF LENIOLISIB FOR THE TREATMENT OF APDS IN JAPAN
Source text for Eikon: ID:nPn1vZnMha
Further company coverage: PHAR.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))